Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q3 2022 Earnings

8AugConfirmed

Q4 2021

Q1 2022

Q2 2022

Q3 2022

-0.67

-0.48

-0.28

-0.09

Details

Expected EPS

-0.24

Actual EPS

-0.21

Surprise EPS

0.03

Surprise Percent

+12.5%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.21 per share for Q3 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.